Tells shareholders in April 11 letter that it has "sent bid requests to those prospective purchasers with whom we have been working" and expects bids to be received within two weeks. The firm says it "should be engaged thereafter in negotiating the final terms of an agreement for the sale of your company to one of the bidders." Scherer has been providing corporate information and showing facilities to a "number of prospective purchasers" during the last several months, the letter states.
You may also be interested in...
In this new roundup feature focusing on the most notable developments in digital health, we pick the key news from the year so far.
US Regulatory Roundup, February 2021: QA/RA Predictions, FDA Warning Letter Stats, PMA Case Study, And More
Quality and regulatory predictions for 2021, a count of 2020 US FDA enforcement missives, a premarket approval case study for a novel prosthetic, and more topped our list of most-read Medtech Insight articles in February.
Locke Lord senior counsel Sharon Blinkoff shares perspective from her experience defending smaller cosmetics companies against US class action plaintiff demands and litigation.